EPFL spin-off Bicycle Therapeutics floats on Nasdaq

EPFL spin-off Bicycle Therapeutics floats on Nasdaq

24.5.2019 – EPFL spin-off Bicycle Therapeutics carried out an IPO this past Wednesday and raised $60.6 million. The proceeds will be used to conduct further clinical trials of its cancer drugs. That makes Bicycle Therapeutics the third EPFL spin-off to go public, following in the footsteps of Logitech and Biocartis.

read more on EPFL News